About Therdose Pharma Private Limited
Data last updated:
Therdose Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Vance And Health Pharmaceuticals Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC042272. Its GSTIN is 36AAACO6469N1ZT (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.99 Cr. It was formerly known as Oshadha Therapeutics Private Limited. It is led by directors including Ratna Sekhar Rao Imadabathuni (Managing Director) and Mahindra Dev Imadabathuni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.66 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹4.9 Cr (net margin -18.4%) and EBITDA of -₹1.89 Cr (EBITDA margin -7.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.
The company has about 137 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: TherDose. As per MCA filings, the company has open charges of ₹11.58 Cr and satisfied charges of ₹24.13 Cr on record. Court records list 24 cases involving the company, including 9 filed by the company and 15 filed against it; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website therdose.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.118 119 & 120 Survey No.342 Aleap Industrialestate Opp:Jntu Pragati Nagar, Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Therdose Pharma Private Limited
Therdose Pharma has one previous CIN (Corporate Identification Number): U24239AP2003PTC042272. The current CIN is U24239TG2003PTC042272, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC042272 | Current |
| U24239AP2003PTC042272 | Previous |
Associated Brands with Therdose Pharma Private Limited
Therdose Pharma operates one associated brand: TherDose. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology-focused generic and specialty drugs are developed and manufactured. | therdose.com |
Business Activity of Therdose Pharma Private Limited
The main business activity of Therdose Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Therdose Pharma Private Limited
Therdose Pharma Private Limited is audited by R B ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R B ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Therdose Pharma Private Limited
Therdose Pharma has 7 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meka Kesava Sambasiva Rao Also directs: DHS Hotels Private Limited | Director | 26 Nov 2021 | 4 Years 10 Months | Current |
| Narayana Raju Mantana Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 15 Apr 2024 | 2 Years 5 Months | Current |
| Arvind Reddy Panyala Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 26 Nov 2021 | 4 Years 10 Months | Current |
| Mahindra Dev Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Whole-Time Director | 26 Nov 2021 | 4 Years 10 Months | Current |
| Raja Vakula Devi Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 03 Oct 2022 | 4 Years 0 Months | Current |
| Ratna Sekhar Rao Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Managing Director | 12 Nov 2021 | 4 Years 10 Months | Current |
Financials of Therdose Pharma Private Limited FY 2024 filings available
Therdose Pharma Private Limited reported revenue of ₹26.66 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Therdose Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 12% growth in the latest year. EBITDA fell 197% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Therdose Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.89 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.9 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Therdose Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -18.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Therdose Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Therdose Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Therdose Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2022 | Others | ₹11.58 Cr | Open |
| 06 May 2022 | Axis Bank Limited | ₹25.68 Lakh | Satisfied |
| 31 Jul 2018 | Others | ₹58.75 Lakh | Satisfied |
| 31 Jul 2015 | Reliance Capital Ltd | ₹74 Lakh | Satisfied |
| 21 Mar 2012 | Others | ₹12.65 Cr | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Therdose Pharma Private Limited
Therdose Pharma Private Limited has a workforce of 137 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Therdose Pharma Private Limited
Therdose Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACO6469N1ZT | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Therdose Pharma Private Limited
Therdose Pharma Private Limited has 24 court cases on record: 9 filed by Therdose Pharma, 15 filed against it. 12 cases are pending and 12 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 3 |
| High courts | 9 | 0 | 8 |
| NCLAT | 4 | 4 | 1 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Neogrowth Credit Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by HDFC Bank Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against Union of India | Pending |
Full case history
All 24 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Therdose Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Therdose Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Therdose Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Therdose Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Therdose Pharma Private Limited
Frequently Asked Questions about Therdose Pharma Private Limited
Therdose Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 19 December 2003 (23+ years old) and is registered under CIN U24239TG2003PTC042272.
Therdose Pharma reported revenue of ₹26.66 Cr for FY 2025 (up 12% YoY).
Therdose Pharma has 7 current directors:
- Ratna Sekhar Rao Imadabathuni - Managing Director
- Mahindra Dev Imadabathuni - Whole-Time Director
- Meka Kesava Sambasiva Rao - Director
- Narayana Raju Mantana - Director
- Arvind Reddy Panyala - Director
- Raja Vakula Devi Imadabathuni - Director
- Mantena Raju Narasa - Director
Therdose Pharma reported a net loss of ₹4.9 Cr (net margin -18.4%) and EBITDA of -₹1.89 Cr (EBITDA margin -7.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Therdose Pharma is 4% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Therdose Pharma is 36AAACO6469N1ZT, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Therdose Pharma is U24239TG2003PTC042272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Therdose Pharma has 24 court cases on record: 9 filed by the company and 15 filed against it. 12 are pending. Most are in the district courts.
Therdose Pharma was incorporated on 19 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.